Immune-checkpoint Inhibitors and Surrogate Endpoints in Cancer Trials (SURROGATE-ICI)

Clinical trial NCT03963518 · COMPLETED

Trial details

NCT number: NCT03963518
Sponsor: Institut Bergonié
Status: COMPLETED
Study type: OBSERVATIONAL

Cancer Treated With Immune-checkpoint Inhibitors

Start date: 2017-01-01
Primary completion: 2020-12-01
Enrollment: 631

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.